Skip to main content

Peer Review reports

From: The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience

Original Submission
17 Dec 2013 Submitted Original manuscript
18 Dec 2013 Author responded Author comments - Dieter Buchheidt
Resubmission - Version 2
18 Dec 2013 Submitted Manuscript version 2
30 Jan 2014 Reviewed Reviewer Report - Sercan Aksoy
15 Feb 2014 Reviewed Reviewer Report - Peter McLaughlin
10 Apr 2014 Reviewed Reviewer Report - Ivanka Hadji-Petrusheva Meloska
3 May 2014 Author responded Author comments - Dieter Buchheidt
Resubmission - Version 3
3 May 2014 Submitted Manuscript version 3
4 May 2014 Author responded Author comments - Dieter Buchheidt
Resubmission - Version 4
4 May 2014 Submitted Manuscript version 4
20 May 2014 Reviewed Reviewer Report - Peter McLaughlin
26 May 2014 Author responded Author comments - Dieter Buchheidt
Resubmission - Version 5
26 May 2014 Submitted Manuscript version 5
16 Jun 2014 Author responded Author comments - Dieter Buchheidt
Resubmission - Version 6
16 Jun 2014 Submitted Manuscript version 6
Publishing
18 Jun 2014 Editorially accepted
3 Jul 2014 Article published 10.1186/1471-2334-14-364

You can find further information about peer review here.

Back to article page